期刊文献+

P物质在成骨细胞分化过程中对转录因子Osterix表达的影响 被引量:2

Effect of substance P on expression of Osterix in osteoblast differentiation
下载PDF
导出
摘要 目的:在成骨细胞分化过程中检测转录因子Osterix的表达,探讨P物质调控成骨细胞分化及骨形成的分子机制.方法:原代培养大鼠骨髓基质干细胞(rMSCs),并诱导其向成骨细胞定向分化.采用RT-PCR法检测转录因子Osterix在P物质和/或P物质NK1受体拮抗剂L732138干预下的表达.结果:在诱导成骨细胞定向分化的过程中,与空白对照组相比,P物质组转录因子Osterix的表达增强(LSD-t=0.117,P<0.01),P物质NK1受体拮抗剂L732138组转录因子Osterix的表达差异无统计学意义(LSD-t=0.008,P>0.05);与P物质组相比,P物质与P物质NK1受体拮抗剂L732138组转录因子Osterix的表达降低(LSD-t=-0.172,P<0.01).结论:P物质可以促进转录因子Osterix的表达,其受体拮抗剂L732138具有拮抗作用;P物质可通过促进转录因子Osterix的表达,促进成骨细胞分化及骨形成. AIM: To explore the molecular pathway of substance P-induced osteoblast differentiation. METHODS: Mesenchymal stem cells of rats (rMSCs) were isolated, cultured and induced to differentiate osteoblast. Under the interference of substance P or/ and substance P antagonist L732138, total RNA was extracted and Osterix gene expression was evaluated by RT-PCR. RESULTS: Compared with that in normal control group, the expression of Osterix increased significantly in substance P group( LSD-t = 0.117, P 〈0.01 ) in the course of osteoblast differentiation, but no sig- nificant difference was seen compared with that in substance P receptor antagonist L732138 group ( LSD-t = 0. 008, P 〉 0.05 ). Compared with that in substance P group, the 0sterix expression decreased significantly in the federal group of substance P and substance P receptor antagonist L732138 ( LSD-t = - 0. 172, P 〈 0.01 ). CONCLUSION: Substance P stimulates the expression of Osterix, which can be depressed by substance P receptor antag- onist L732138. Substance P stimulates osteoblast differentiation by stimulating the expression of Osterix.
出处 《第四军医大学学报》 CAS 北大核心 2009年第5期431-434,共4页 Journal of the Fourth Military Medical University
关键词 P物质 成骨细胞 分化 Osterix转录因子 substance P osteoblast differentiation Osterix
  • 相关文献

参考文献10

  • 1Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation [ J ]. Cell, 2002,108 ( 1 ) : 17 - 29.
  • 2Gao Y, Jheon A, Nourkeyhani H, et al. Molecular cloning, structure, expression, and chromosomal localization of the human Osterix (SP7) gene[J]. Gene, 2004,341:101 - 110.
  • 3Wade K, Sarah CO, Tian-Zhi G, et al. A substance P receptor (NK1) antagonist enhances the widespread osteoporotic effects of sciatic nerve section [ J ]. Bone, 2003,33:927 - 936.
  • 4Komori T. Regulation of skeletal development by the Runx family of transcription factors [ J ]. J Cell Biochem, 2005,95 ( 3 ) :445 - 453.
  • 5Katagiri T, Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation[ J]. Oral Dis, 2002,8(3 ) : 147 - 159.
  • 6Nakashima K, de Crombrugghe B. Transcriptional mechanisms in osteoblast differentiation and bone formation[ J]. Trends Genet,2003, 19(8) :458 -466.
  • 7Lundberg P, Lerner UH. Expression and regulatory role of receptors for vasoactive intestinal peptide in bone cells [ J ]. Microsc Res Tech ,2002,58:98 - 103.
  • 8Imai S, Matsusue Y. Neuronal regulation of bone metabolism and anabolism: Calcitonin gene-related peptide-, substance P-and tyrosine hydroxylase-containing nerves and the bone [ J ]. Microsc Res Tech, 2002,58:61 -69.
  • 9Varga AC, Wrana JL. The disparate role of BMP in stem cell biology [J]. Oncogene, 2005,24(37) :5713 -5721.
  • 10郭世绂.骨质疏松症的药物治疗及其理论基础[J].中华骨科杂志,2004,24(11):691-695. 被引量:52

共引文献51

同被引文献41

  • 1李淑梅,宋利格,张秀珍.淫羊藿甙对大鼠成骨细胞功能及Osterix表达的影响[J].同济大学学报(医学版),2005,26(6):8-11. 被引量:29
  • 2程敏,李祥伟,苗雷英,余宏天,孙宏晨.人牙齿发育中OSX的表达[J].口腔医学研究,2006,22(4):372-375. 被引量:2
  • 3孙冬梅,刘中博,赵岩,宫振伟,李丹,王溪原,曾宪录,刘文广.Runx2参与调控Osterix启动子活性及其基因表达(英文)[J].生物化学与生物物理进展,2006,33(10):957-964. 被引量:21
  • 4Chambers TJ, Hall TJ. Cellular and molecular mechanisms in the regulation and function of osteoclasts[ J]. Vitam Horm, 1991,46: 41 -86.
  • 5Nakashima K,Xin Z,Kunkel G,et al. The novel zinc finger-con- taining transcription factor osterix is required for osteoblast differentiation and bone formation [ J ]. Ce11,2002,108 ( 1 ) : 17 - 29.
  • 6Ohyama Y, Nifuji A, Maeda Y, et al. Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis [ J ]. Endocrinolgy, 2004,145 (10) :4685 - 4692.
  • 7Uisamer A, Ortuno MJ, Ruiz S, et al. BMP-2 induces osterix ex- pression through up-regulation of Dlx5 and its phosphorylation by p38 [ J]. J Biol Chem,2008,283 ( 7 ) :3816 - 3826.
  • 8Celil AB,Camphbell PG. BPM-2 and insulin-like growth factor-I mediate osterix(Osx) expression in human mesenchymal stem cell via the MAPK and protein kinase D signaling pathways[ J]. J Biol Chem,2005,280(36) :31353 -31359.
  • 9Nakashima K,Xin Z,Kunkel G. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation[J].Cell,2002,(01):17-29.
  • 10Ohyama Y,Nifuji A,Maeda Y. Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis[J].Endocrinology,2004,(10):4685-4692.

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部